C013: Zaltrap / Eylea Biosimilar Stable Cell Line (CHO)
The yield of Zaltrap / Eylea biosimilar from the CHO stable cell line was above 2.1 g/L in a 3 liter manufacturing.
C013P: Aflibercept Biosimilar
Recombinant protein composed of the binding domains of two human vascular endothelial growth factor (VEGF) receptors fused with the Fc region of human immunoglobulin gamma 1 (IgG1).
Specificity/Sensitivity: The aflibercept biosimilar protein specifically binds to the human VEGF.
Applications: Functional assays, and those assays for studying biological pathways affected by aflibercept.
2 products and services found for "zaltrap eylea biosimilar stable cell line"
Please click zaltrap eylea biosimilar stable cell line to try advanced search.
About our zaltrap eylea biosimilar stable cell line products
2 zaltrap eylea biosimilar stable cell line products are offered for sale on sydlabs.com, and welcome to contact us if you are interested in more zaltrap eylea biosimilar stable cell line related products, which may be under development and close to be listed for sale. We have always tried our best to reduce cost to offer the cheapest zaltrap eylea biosimilar stable cell line products.
Related Searches